Combined organ-preserving therapy for cancer of the penis
https://doi.org/10.17650/1726-9776-2006-2-4-50-52
Abstract
Intratissue radiotherapy with Co60 sources in combination with gamma-teletherapy was used in 11 patients with penile carcinoma as organpreserving treatment. In this group of patients, 5-year relapse-free survival was 91.6%. Along with high survival rates, this treatment modality assured a high quality of life. Combined radiotherapy is most effective and advisable in patients with T1-T2.
About the Authors
A. D. Kaprin
Russian X-Ray Radiology Research Center, Russian Ministry of Health
Russian Federation
Russian Federation
O. A. Zamyatin
Russian X-Ray Radiology Research Center, Russian Ministry of Health
Russian Federation
Russian Federation
K. N. Milenin
Russian X-Ray Radiology Research Center, Russian Ministry of Health
Russian Federation
Russian Federation
A. A. Kostin
Russian X-Ray Radiology Research Center, Russian Ministry of Health
Russian Federation
Russian Federation
References
1. Solsona E., Algaba F., Horenblas S. et al. EAU Guidelines on Penile Cancer. Eur Urol 2004; 46(1): 1–8.
2. Матвеев В.Б., Халафьян Э.А., Волкова М.И. и др. Органосохраняющее лечение рака полового члена. Урол и нефрол 2004;(2):26–30.
Review
For citations:
Kaprin A.D., Zamyatin O.A., Milenin K.N., Kostin A.A. Combined organ-preserving therapy for cancer of the penis. Cancer Urology. 2006;2(4):50-52. (In Russ.) https://doi.org/10.17650/1726-9776-2006-2-4-50-52
Views:
298
Email this article 